HK1033275A1 - Remedy for hepatopathy. - Google Patents

Remedy for hepatopathy.

Info

Publication number
HK1033275A1
HK1033275A1 HK01103997A HK01103997A HK1033275A1 HK 1033275 A1 HK1033275 A1 HK 1033275A1 HK 01103997 A HK01103997 A HK 01103997A HK 01103997 A HK01103997 A HK 01103997A HK 1033275 A1 HK1033275 A1 HK 1033275A1
Authority
HK
Hong Kong
Prior art keywords
hepatic
caused
active ingredient
compositions
acids
Prior art date
Application number
HK01103997A
Other languages
English (en)
Inventor
Susumu Satomi
Hideyuki Doi
Masahiro Chin
Hiromichi Komatsu
Hiroshi Koga
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of HK1033275A1 publication Critical patent/HK1033275A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK01103997A 1997-09-30 2001-06-11 Remedy for hepatopathy. HK1033275A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26579397 1997-09-30
PCT/JP1998/004405 WO1999016433A1 (fr) 1997-09-30 1998-09-30 Medicament pour l'hepatopathie

Publications (1)

Publication Number Publication Date
HK1033275A1 true HK1033275A1 (en) 2001-08-24

Family

ID=17422126

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01103997A HK1033275A1 (en) 1997-09-30 2001-06-11 Remedy for hepatopathy.

Country Status (11)

Country Link
EP (2) EP1714649A3 (xx)
KR (2) KR100562739B1 (xx)
CN (1) CN1149988C (xx)
AT (1) ATE336241T1 (xx)
AU (1) AU9280298A (xx)
CA (1) CA2305206A1 (xx)
DE (1) DE69835609T2 (xx)
HK (1) HK1033275A1 (xx)
TW (1) TW473387B (xx)
WO (1) WO1999016433A1 (xx)
ZA (1) ZA988924B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660771B1 (en) 1999-08-23 2003-12-09 Chugai Seiyaku Kabushiki Kaisha Remedies for liver regeneration of transplanted liver
TWI266614B (en) 2000-10-13 2006-11-21 Chugai Pharmaceutical Co Ltd Compositions comprising valine for improving lipid metabolism
WO2003063853A1 (fr) * 2002-01-31 2003-08-07 Chugai Seiyaku Kabushiki Kaisha Compositions de reduction de la graisse mesenterique
JP5720569B2 (ja) * 2009-06-24 2015-05-20 味の素株式会社 核酸アナログの活性増強剤
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
IL296055A (en) 2017-08-14 2022-10-01 Axcella Health Inc Amino acid compounds for the treatment of liver disease
AR115585A1 (es) 2018-06-20 2021-02-03 Axcella Health Inc Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5668374A (en) * 1979-11-08 1981-06-09 Jun Sawada Food composition for hepatic insufficiency
JPS61186320A (ja) * 1985-02-12 1986-08-20 Morishita Seiyaku Kk アミノ酸製剤
JP2618653B2 (ja) * 1987-09-22 1997-06-11 ルセル森下株式会社 肝性脳症患者用アミノ酸製剤
EP0605742A4 (en) * 1992-06-26 1996-01-03 Nonna Dmitrievna Kislyakova Agent with adaptogenic activity.
AU2629895A (en) * 1994-06-23 1996-01-19 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for liver regeneration

Also Published As

Publication number Publication date
CN1278168A (zh) 2000-12-27
ATE336241T1 (de) 2006-09-15
AU9280298A (en) 1999-04-23
ZA988924B (en) 1999-03-30
EP1025844B1 (en) 2006-08-16
EP1025844A1 (en) 2000-08-09
KR20050054921A (ko) 2005-06-10
KR100562739B1 (ko) 2006-03-20
EP1025844A4 (en) 2002-10-02
DE69835609T2 (de) 2007-08-09
KR20010030820A (ko) 2001-04-16
EP1714649A2 (en) 2006-10-25
DE69835609D1 (de) 2006-09-28
WO1999016433A1 (fr) 1999-04-08
TW473387B (en) 2002-01-21
CA2305206A1 (en) 1999-04-08
EP1714649A3 (en) 2007-09-05
CN1149988C (zh) 2004-05-19

Similar Documents

Publication Publication Date Title
MXPA01007666A (es) Granulos a base de almidon y de lactosa.
CA2146633A1 (en) Concentrated bioavailable calcium source
FI844364A0 (fi) Produkt, som kan foeraendras.
ATE296545T1 (de) Zusatz für die wiederherstellung des wachstumhormonspiegels
NO992463D0 (no) N-(aryl/heteroarylacetyl)aminosyreestere, farmas°ytiske sammensetninger som omfatter det samme, og metoder for inhibering av <beta>-amyloidpeptidfrigivelse og/eller dens syntese ved bruk av slike forbindelser
HK1033275A1 (en) Remedy for hepatopathy.
EP0402755A3 (de) L-Carnitin-Magnesium-Zitrat
CA2269107A1 (en) Clamping member for at least one support pin for belt conveyor components
HAGIHIRA et al. INTESTINAL ABSORPTION OF AMINO ACIDS III. INTERFERENCE BETWEEN AMINO ACIDS DURING INTESTINAL ABSORPTION
DK0948328T3 (da) Sammensætninger baseret på aminosyrer
JP2003034643A5 (xx)
PL352578A1 (en) Dietary supplement for containing alknoyl derivative of carnitin and ribose for ehnancing energetic metabolism of muscles
ES2163419T3 (es) Composiciones nutritivas para el tratamiento del metabolismo del nitrogeno.
ES2099676A1 (es) Nuevo producto de fibra de cacao a base de cascara de cacao tostada.
GB9401447D0 (en) Pharmaceutical compositions
NZ228208A (en) Eglin compounds (hurudin) and protease inhibitor pharmaceutical compositions
ES2168508T3 (es) Empleo de treonina para el tratamiento de fenil-cetonuria.
EP1607399A3 (en) BIS-(N,N'-BIS-(2-Haloethyl)Amino) Phosphoramidates as antitumor agents
JPS54120607A (en) Prevention of heat browning of phospholipid
EP0624368A3 (en) Use of a composition to stimulate glutathione synthesis for the manufacture of a medicament for the treatment of AID.
EP1306366A3 (en) New dibenzosuberone derivatives
CA2203228A1 (en) Gluten lactose blends
Andersen et al. Effects of DDC and related compounds on cadmium toxicokinetics
BG51857A1 (en) Product for sportsmen feeding
HUP0100634A2 (hu) Pentaeritrit-tetranitrátot tartalmazó gyógyászati készítmények

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080930